June 2020

Pharmacists must be able to identify populations that are at high risk for influenza complications.

At the completion of this activity, the participant will be able to determine appropriate treatment options for a patient with relapsed or refractory FL or MCL.

At at virtual panel discussion held in conjunction with the Asembia Specialty Pharmacy Summit, several experts covered chronic inflammatory demyelinating polyneuropathy (CIDP).

This continuing education activity is supported by an educational grant from Genentech.

This continuing education activity is supported by an educational grant from Takeda.

This cancer is characterized by scar tissue accumulation in the bone marrow, which leads to an insufficient quantity of normal blood cells.

This continuing education activity is supported by an educational grant from CSL Behring.

Because HAE is a rare disease, diagnostic delay is a problem as clinicians try to link unusual symptoms with a diagnosis.

At just 1.2%, chronic lymphocytic leukemia represents a small percentage of all new cancer cases but is the most common leukemia in Western countries.

Myelodysplastic syndromes (MDS) can develop de novo (from unknown causes) or pursuant to the use of alkylating agents or topoisomerase inhibitors.

In a virtual symposium held in conjunction with the Asembia Specialty Pharmacy Summit, 2 speakers covered the numerous care improvements developed for cystic fibrosis over the past 10 to 20 years.

A virtual symposium held on optimizing care for patients with inflammatory bowel disease (IBD) was held in conjunction with the Asembia Specialty Pharmacy Summit.

A virtual symposium held in conjunction with the Asembia Specialty Pharmacy Summit focused on psoriatic arthritis.

By 2050, statisticians indicated that approximately 22 million people will be affected by macular degeneration or wet AMD.

This continuing education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

This continuing education activity is supported by an educational grant from CSL Behring.

There has been growing evidence supporting new therapeutic approaches for this heterogenous group of diseases.

Visual impairment confers a tremendous psychosocial burden, yet up to half of atrisk patients skip annual eye examinations. symposium held in conjunction with the Asembia Specialty Pharmacy Summit, noting that up to 17% of cases of blindness can be attributed to diabetic eye disease.

A virtual symposium presented in conjunction with the Asembia Specialty Pharmacy Summit focused on current and emerging therapies while differentiating therapeutic advantages among current products and management strategies.

Patients with this chronic, progressive illness may encounter a wealth of drug-related issues that clinicians need to navigate through a coordinated, multidisciplinary approach.

In a virtual symposium, 2 speakers discussed the common primary immunodeficiency disorders and their effects on patients’ quality of life.

The past decade has seen a rapid expansion in technology adoption.

In this time of crisis, the scope of pharmacy practice has been expanded and pharmacists can provide even more care.

One of the advantages of specialty pharmacy is the ability to work remotely without compromising the care that pharmacists give to their patients.

The best patient and provider experience will result in a coordination of efforts across the channel continuum.